Logo
x

Search

Subscribe Now

hypertension

Omada Health Launches the First Virtual Cardiometabolic Clinic for Patients with Diabetes and Hypertension

Omada Health Launches the First Virtual Cardiometabolic Clinic for Patients with Diabetes and Hypertension

  • April 16, 2021
AstraZenca Expands Supply Agreement with Cheplapharm for Atacand (candesartan cilexetil) and Atacand Plus (candesartan cilexetil + hydrochlorothiazide) to Cheplapharm

AstraZenca Expands Supply Agreement with Cheplapharm for Atacand (candesartan cilexetil) and Atacand Plus (candesartan cilexetil +...

  • October 30, 2020
AstraZeneca to Divest its Hypertension Therapies to Atnahs Pharma

AstraZeneca to Divest its Hypertension Therapies to Atnahs Pharma

  • January 27, 2020
Exelixis and Daiichi Report Launch of Minnebro (Esaxerenone) Tablets for Hypertension in Japan

Exelixis and Daiichi Report Launch of Minnebro (Esaxerenone) Tablets for Hypertension in Japan

  • May 14, 2019
Exelixis and Daiichi Sankyo's Minnebro (Esaxerenone) Receives MHLW Marketing Approval In Patients With Hypertension In Japan

Exelixis and Daiichi Sankyo's Minnebro (Esaxerenone) Receives MHLW Marketing Approval In Patients With Hypertension In Japan

  • January 9, 2019
Mylan Recalls 15 Batches of Valsartan Globally- for the Treatment of Hypertension

Mylan Recalls 15 Batches of Valsartan Globally- for the Treatment of Hypertension

  • November 21, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.